ReviewOncology research2026

Therapeutic Targets for Overcoming BCR::ABL1 Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.

Masanobu Tsubaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.